Woman want sex Denali

Added: Iisha Guillemette - Date: 04.12.2021 02:12 - Views: 43967 - Clicks: 8687

Study record managers: refer to the Data Element Definitions if submitting registration or information. Latanoprost 0. Talk with your doctor and family members or friends about deciding to a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or information. Search for terms. Save this study. Warning You have reached the maximum of saved studies Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension Denali The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.

Listing a study does not mean it has been evaluated by the U. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Last Update Posted : March 29, See Contacts and Locations. Study Description. The objective of this clinical study is to evaluate the safety and efficacy of NCX Ophthalmic Solution in lowering intraocular pressure IOP in subjecs with ocular hypertension or open-angle glaucoma. Subjects will be randomized in a ratio to NCX 0. MedlinePlus related topics: Glaucoma.

Drug Information available for: Latanoprost. FDA Resources. Arms and Interventions. Latanoprost Ophthalmic Solution, 0. Outcome Measures. and percentage of subjects with ocular and non-ocular treatment-emergent adverse events. Percentage of subjects in each treatment group who discontinue study participation.

Eligibility Criteria. Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Inclusion Criteria: Diagnosis of open-angle glaucoma or ocular hypertension in both eyes Qualifying IOP at 3 time points through the day at 2 visits following washout of IOP-lowering medication, if applicable Qualifying best-corrected visual acuity in each eye Ability to provide informed consent and follow study instructions Exclusion Criteria: Narrow anterior chamber angles or disqualifying corneal thickness in either eye Clinically ificant ocular disease in either eye complicated surgery or certain types of glaucoma surgery in either eye Incisional ocular surgery or severe trauma in either eye within the past 6 months Uncontrolled systemic disease.

Contacts and Locations. Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials. More Information. National Library of Medicine U. National Institutes of Health U. Department of Health and Human Services. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.

Open Angle Glaucoma Ocular Hypertension. Drug: NCX 0. Phase 3. Study Type :. Interventional Clinical Trial. Estimated Enrollment :. Actual Study Start Date :. Estimated Primary Completion Date :. Estimated Study Completion Date :. Experimental: NCX 0. Active Comparator: Latanoprost 0. Drug: Latanoprost 0. Contact: Linda Wirta November 16, Key Record Dates.

Woman want sex Denali

email: [email protected] - phone:(887) 569-5859 x 8894

Woman ple guilty to running a sex-trafficking ring, sentenced to 5 1/2 years